How big is the edible vaccine market today, and what are its future growth expectations?
The edible vaccine market size has grown strongly in recent years. It will grow from $8.77 billion in 2024 to $9.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to advancements in genetic engineering, challenges with traditional vaccines, advances in biopharming, growing focus on global immunization, and increasing funding and support from governments.
The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $13.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the growing demand for pandemic preparedness, advancements in plant biotechnology, growing public awareness and acceptance of genetically modified foods, addressing cold chain challenges, and integration with food security initiatives. Major trends in the forecast period include expansion into animal health, increased use of biopharming, personalized nutrition and vaccination, sustainability and green vaccines, and the development of multi-antigen edible vaccines.
Get Your Free Sample of The Global Edible Vaccine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp
What have been the primary factors driving the edible vaccine market’s growth?
The increasing prevalence of infectious diseases is expected to propel the growth of the edible vaccine market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and multiply. The increasing prevalence of infectious diseases is mainly due to factors such as globalization, climate change, urbanization, and antibiotic resistance, which facilitate the spread and emergence of new pathogens. Edible vaccines are used in infectious diseases to stimulate immune responses by consuming genetically modified foods that produce antigens, offering a cost-effective and needle-free method of immunization. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Additionally, the rate per 100,000 people went up from 2.5 in 2022 to 2.9 in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the edible vaccine market.
What are the key segments within the edible vaccine market?
The edible vaccinemarket covered in this report is segmented –
1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals
Subsegments:
1) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
2) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
3) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Synthetic DNA Vaccines
4) By Live Attenuated Vaccines: Live Attenuated Viral Vaccines, Live Attenuated Bacterial Vaccines
5) By Other Types: Virus-Like Particle (VLP) Vaccines, mRNA Vaccines
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report
Which key players are shaping the edible vaccine market?
Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation
How will emerging trends drive the edible vaccine market throughout the forecast period?
Major companies operating in the edible vaccine market are focusing on developing innovative solutions, such as oral cholera vaccine (OCV), to combat the global cholera crisis. Oral cholera vaccine (OCV) is a type of vaccine administered by mouth to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For instance, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, launched the Hillchol, an oral cholera vaccine (OCV) with several notable features. This live-attenuated vaccine stimulates both systemic and mucosal immune responses, protecting against cholera. Hillchol stands out for its ease of administration and does not require cold storage, making it ideal for use in resource-limited settings. Moreover, it offers long-lasting immunity with just a single dose.
How do regional factors impact the edible vaccine market, and which region is the largest contributor?
North America was the largest region in the edible vaccine market in 2024. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Edible Vaccine Market Report 2025 Offer?
The edible vaccine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
An edible vaccine is a type of vaccine produced in genetically modified plants or animals, where the vaccine is delivered through consumption rather than by injection. These vaccines stimulate an immune response in the body when an edible plant or food, such as a fruit or vegetable, is eaten. The concept aims to offer a cost-effective and easily accessible alternative to traditional vaccines, especially in developing countries.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19040
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
